BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND TOP1, RP3-511B24_2, 7150, ENSG00000198900, TOPI, P11387 AND Prognosis
4703 results:

  • 1. Differentially expressed genes associated with high metabolic tumor volume served as diagnostic markers and potential therapeutic targets for pancreatic cancer.
    Kim BG; Lee SH; Jang Y; Kang S; Kang CM; Cho NH
    J Transl Med; 2024 May; 22(1):453. PubMed ID: 38741142
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Precise planning based on 3D-printed dry-laboratory models can reduce perioperative complications of laparoscopic surgery for complex hepatobiliary diseases: a preoperative cohort study.
    Yao WF; Huang XK; Fu TW; Jin L; Du CF; Gao ZY; Wang KD; Dai MG; Liu SY; Liu JW; Zhang CW; Liang L; Huang DS
    BMC Surg; 2024 May; 24(1):148. PubMed ID: 38734630
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Analysis of factors affecting the prognosis of patients with pancreatic cancer patients with obstructive jaundice].
    Zhang L; Li M; Sun QF; Yu HP
    Zhonghua Nei Ke Za Zhi; 2024 May; 63(5):474-479. PubMed ID: 38715484
    [No Abstract]    [Full Text] [Related]  

  • 4. Prognostic significance of preoperative lymphocytes, albumin, and neutrophils (LANR) index in resectable pancreatic ductal adenocarcinoma.
    Zhuang J; Wang S; Wang Y; Wu Y; Hu R
    BMC Cancer; 2024 May; 24(1):568. PubMed ID: 38714979
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Treatment strategies for borderline resectable pancreatic neuroendocrine tumors: a narrative review.
    Chang JY; Ruff SM; Cloyd JM
    Chin Clin Oncol; 2024 Apr; 13(2):25. PubMed ID: 38711178
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Adjuvant chemotherapy omission after pancreatic cancer resection: a French nationwide study.
    Poiraud C; Lenne X; Bruandet A; Theis D; Bertrand N; Turpin A; Truant S; El Amrani M
    World J Surg Oncol; 2024 May; 22(1):123. PubMed ID: 38711136
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma.
    Li F; Si W; Xia L; Yin D; Wei T; Tao M; Cui X; Yang J; Hong T; Wei R
    Mol Cancer; 2024 May; 23(1):90. PubMed ID: 38711083
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Analysis of chemoresistance characteristics and prognostic relevance of postoperative gemcitabine adjuvant chemotherapy in pancreatic cancer.
    Ren J; Wu S; Su T; Ding J; Chen F; Li J; Wang Z; Han L; Wu Z
    Cancer Med; 2024 May; 13(9):e7229. PubMed ID: 38698688
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Targeting KRAS in pancreatic cancer.
    Stickler S; Rath B; Hamilton G
    Oncol Res; 2024; 32(5):799-805. PubMed ID: 38686056
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The Albumin-bilirubin Grade as Prognostic Indicator for Recurrent Hepatocellular Carcinoma Needing Repeat Liver Resection.
    Gon H; Komatsu S; Omiya S; Kido M; Fukushima K; Urade T; Yoshida T; Arai K; Ishida J; Nanno Y; Tsugawa D; Yanagimoto H; Toyama H; Fukumoto T
    Anticancer Res; 2024 May; 44(5):2031-2038. PubMed ID: 38677757
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Optimal surgical management of unifocal vs. multifocal NF-PNETs: a respective cohort study.
    Kim J; Hong SS; Kim SH; Hwang HK; Kang CM
    World J Surg Oncol; 2024 Apr; 22(1):115. PubMed ID: 38671431
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Pan-cancer analysis implicates novel insights of lactate metabolism into immunotherapy response prediction and survival prognostication.
    Chen D; Liu P; Lu X; Li J; Qi D; Zang L; Lin J; Liu Y; Zhai S; Fu D; Weng Y; Li H; Shen B
    J Exp Clin Cancer Res; 2024 Apr; 43(1):125. PubMed ID: 38664705
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Minocycline and photodynamic priming significantly improve chemotherapy efficacy in heterotypic spheroids of pancreatic ductal adenocarcinoma.
    Bano S; Alburquerque JQ; Roberts HJ; Pang S; Huang HC; Hasan T
    J Photochem Photobiol B; 2024 Jun; 255():112910. PubMed ID: 38663337
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic value of combined psoas muscle mass and controlling nutritional status in patients with pancreatic ductal adenocarcinoma: a retrospective cohort study.
    Kuwabara S; Takeuchi Y; Sato O; Mizota T; Ichinokawa M; Murakawa K; Aoki Y; Ishido K; Ono K; Hirano S
    BMC Surg; 2024 Apr; 24(1):116. PubMed ID: 38643112
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Fatty Acid Binding Protein 1 is an Independent Prognostic Biomarker for Gallbladder cancer with Direct Hepatic Invasion.
    Qiu S; Liu Z; Hu J; Wang Z; Yue Z; Jia Z; Zhang W; Xue Z; Liu Z; Liu Y
    Int J Med Sci; 2024; 21(5):862-873. PubMed ID: 38617005
    [No Abstract]    [Full Text] [Related]  

  • 16. A 15-Inflammation-Related Gene Signature Predicts the prognosis of Patients With pancreatic Ductal Adenocarcinoma.
    Sun X; Song H; Sun X; Liao C; Wang G; Xu Y; Li L; Han Y; Xu C; Wang W; Cai S; Liang H; Yu H
    Cancer Invest; 2024 Mar; 42(3):226-242. PubMed ID: 38616304
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Identification of Novel Cuproptosis-Related Genes Mediating the prognosis and Immune Microenvironment in Cholangiocarcinoma.
    Liu Q; Zhu J; Huang Z; Zhang X; Yang J
    Technol Cancer Res Treat; 2024; 23():15330338241239139. PubMed ID: 38613350
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Nuclear MAST4 Suppresses FOXO3 through Interaction with AKT3 and Induces Chemoresistance in pancreatic Ductal Carcinoma.
    Fujiwara-Tani R; Sasaki T; Bhawal UK; Mori S; Ogata R; Sasaki R; Ikemoto A; Kishi S; Fujii K; Ohmori H; Sho M; Kuniyasu H
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612866
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validation.
    Huang Y; Chen D; Bai Y; Zhang Y; Zheng Z; Fu Q; Yi B; Jiang Y; Zhang Z; Zhu J
    BMC Cancer; 2024 Apr; 24(1):452. PubMed ID: 38605349
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Calix[6]arene dismantles extracellular vesicle biogenesis and metalloproteinases that support pancreatic cancer hallmarks.
    Cordeiro HG; Azevedo-Martins JM; Faria AVS; Rocha-Brito KJP; Milani R; Peppelenbosch M; Fuhler G; de Fátima Â; Ferreira-Halder CV
    Cell Signal; 2024 Jul; 119():111174. PubMed ID: 38604340
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 236.